SARS-CoV-2-PsIV

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameSARS-CoV-2-PsIV
Drug Alias NameSARS-CoV-2-PsIV
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNaval Medical Research Center
China Registration ClassN/A

Develop Information

Active CompaniesNaval Medical Research Center
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A